Sofinnova Partners has invested in a €28m series-A round for Italian biotech company Enthera Pharmaceuticals, which develops therapeutics for autoimmune disorders.
Sofinnova Partners has invested in a €28m series-A round for Italian biotech company Enthera Pharmaceuticals, which develops therapeutics for autoimmune disorders.